DUNNE MICHAEL W. (Chief Scientific Officer) purchased 28.2% of their position (25K shares) of ITERUM THERAPEUTICS PLC on the open market
Open‑market purchase worth $35.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/27/2023ACC: 0001209191-23-059750
Officer· Chief Scientific Officer
Since Aug 2018
+25K
Net shares
Net buyer
$35.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
25K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+25K
Price / share
$1.40
Trade value
$35K
% of position
28.2%
12/22/2023
88.75K→113.75K
Total
Net shares
+25K
Net value
$35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 12/22/2023 | P · Purchase | +25K | $1.40 | $35K | 28.2% | 88.75K | 113.75K |
| Total | +25K | $35K | ||||||
Derivative Transactions0
No derivative transactions reported